Cardiovascular Disease

Vitamin D vs. placebo for prevention of CVD and cancer.

Among patients with COPD, major cardiovascular risk factors were common but inadequately monitored, treated and controlled, researchers reported in the Annals of the American Thoracic Society.

Patients with chronic kidney disease are at high risk for adverse cardiovascular events, even after adjusting for traditional risk factors.

Certain changes to preexisting models that predict risk for cardiovascular events in the general population can help clinicians predict risk for atherosclerotic CVD in patients with chronic kidney disease.

New study data demonstrate a substantial cardiovascular burden and elevated risks in patients who survived acute COVID-19, according to researchers.

Patients with triple-negative breast cancer have a high prevalence of cardiovascular risk factors that increase their risk for noncancer morbidity and mortality, according to study results.

Current treatments for thymic cancers did not significantly increase risk for cardiovascular disease, according to study results presented at American College of Cardiology’s Advancing the Cardiovascular Care of the Oncology Patient.

Among pediatric patients in the Pediatric Pulmonary Hypertension Network, nearly half had group 3 disease, defined as pulmonary hypertension associated with lung disease or hypoxia, researchers reported in the European Respiratory Journal.

The FDA recently cleared a personal ECG device the size of a credit card that can deliver ECGs in as little as 30 seconds. The announcement was the top story in cardiology last week.

A greater risk for long-term cardiovascular outcomes was associated with the development of gestational diabetes than previously thought, according to prospective data presented at The Pregnancy Meeting.